ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

$6.11
-0.11 (-1.69%)
As of Nov 15, 10:51 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 9 60%
Hold 6 40%
Sell 0 0%
Price Target
Analyst Price Target +93.6% upside
Low Target $9.31
Average Target $11.82
High Target $19.97
Current Price $6.11
Current
$6.11
Target
$11.82
$9.31 $11.82 avg $19.97
Scenario Analysis
Bear Case
$9.31
52.5%
Low target
Base Case
$11.82
+93.6%
Avg target
Bull Case
$19.97
+227.1%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$44.40
-86.3% from high
52-Week Low
$4.07
+50.0% from low
Target vs 52W High
$11.82
-73.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%